David W Farnsworth
Overview
Explore the profile of David W Farnsworth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
19
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeLaitsch A, Pridgen J, Tytla A, Peach M, Hu R, Farnsworth D, et al.
J Am Chem Soc
. 2022 Mar;
144(11):4925-4941.
PMID: 35282679
Germline antibodies, the initial set of antibodies produced by the immune system, are critical for host defense, and information about their binding properties can be useful for designing vaccines, understanding...
2.
Morningstar M, Roth T, Farnsworth D, Smith M, Watson K, Buckheit Jr R, et al.
J Med Chem
. 2007 Aug;
50(17):4003-15.
PMID: 17663538
In an ongoing effort to develop novel and potent nonnucleoside HIV-1 reverse transcriptase (RT) inhibitors that are effective against the wild type (WT) virus and clinically observed mutants, 1,2-bis-substituted benzimidazoles...
3.
Smith M, Hose B, Hawkins A, Lipchock J, Farnsworth D, Rizzo R, et al.
J Med Chem
. 2003 May;
46(10):1940-7.
PMID: 12723956
The energies and physical descriptors for the binding of 20 novel 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)benzimidazole analogues (BPBIs) to HIV-1 reverse transcriptase (RT) have been determined using Monte Carlo (MC) simulations. The crystallographic structure...